Natural Capsules Limited
Natural Capsules Limited engages in the manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally. The company offers bovine spongiform encephalopathy and transmissible spongiform encephalopathy-free gelatin, shiny gelatin, sodium lauryl sulfate-free gelatin, halal-certified gelatin, fast-release gelatin, printed gelatin/cellulose, vegetarian, and enteric caps… Read more
Natural Capsules Limited (NATCAPSUQ) - Total Liabilities
Latest total liabilities as of September 2025: ₹1.75 Billion INR
Based on the latest financial reports, Natural Capsules Limited (NATCAPSUQ) has total liabilities worth ₹1.75 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Natural Capsules Limited - Total Liabilities Trend (2022–2025)
This chart illustrates how Natural Capsules Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Natural Capsules Limited Competitors by Total Liabilities
The table below lists competitors of Natural Capsules Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nutrition SC PCL
BK:NTSC
|
Thailand | ฿266.25 Million |
|
New Frontier Minerals Ltd
AU:NFM
|
Australia | AU$164.45K |
|
POSaBIT Systems Corp
OTCQB:POSAF
|
USA | $6.78 Million |
|
Hasen-Immobilien AG
STU:ABHA
|
Germany | €83.22 Million |
|
Adelong Gold Ltd
AU:ADG
|
Australia | AU$702.45K |
|
Calibre
PA:ALWIN
|
USA | €18.95 Million |
|
Northern Minerals & Exploration Ltd
PINK:NMEX
|
USA | $457.52K |
Liability Composition Analysis (2022–2025)
This chart breaks down Natural Capsules Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.77 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Natural Capsules Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Natural Capsules Limited (2022–2025)
The table below shows the annual total liabilities of Natural Capsules Limited from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹1.62 Billion | +9.80% |
| 2024-03-31 | ₹1.48 Billion | +5.13% |
| 2023-03-31 | ₹1.41 Billion | +72.84% |
| 2022-03-31 | ₹812.97 Million | -- |